Navigation Links
Amicus Therapeutics Announces Second Quarter 2008 Financial Results
Date:8/7/2008

re-tax charges for changes in the fair value of warrant liability

Use of Non-GAAP Financial Measures

Amicus' "non-GAAP net loss" and "non-GAAP diluted net loss per common share" financial measures are defined as reported, or GAAP, net loss and diluted net loss per common share excluding certain items further discussed below. Amicus' management uses these non-GAAP financial measures to establish financial goals and to gain an understanding of the comparative financial performance of Amicus from year to year and quarter to quarter. Accordingly, Amicus believes investors' understanding of Amicus' financial performance is enhanced as a result of disclosing these non-GAAP financial measures. Non-GAAP net loss and diluted net loss per common share should not be viewed in isolation or as a substitute for reported, or GAAP net loss and diluted net loss per common share.

(1) Stock option expense -- Non-GAAP net loss and diluted net loss per

common share exclude the impact of the stock option expense recorded

in accordance with SFAS No. 123R. Amicus believes that excluding the

impact of expensing stock options better reflects the recurring

economic characteristics of its business.

(2) Other items -- Non-GAAP net loss and diluted net loss per common

share exclude other unusual or non-recurring items that are evaluated

on an individual basis. Amicus' evaluation of whether to exclude an

item for purposes of determining its non-GAAP financial measures

considers both the quantitative and qualitative aspects of the item,

including, among other things (i) its size and nature, (ii) whether

or not it relates to its ongoing business operations, and (iii)

whether or not Amicus expects it to occur as part of its normal

business on a regular basis. Items excluded for purposes of

determining non-GAAP net loss and
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
2. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
3. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
6. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
9. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
10. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
11. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Pa. , April 1, 2015  Pittman ... the introduction of PLG24, PLG42K, PLG42S, PLG52, and ... with Pittman brush and brushless DC motors and ... The new products add 35 standard motor-gearbox family ... PLG planetary gearboxes deliver high torque loads with ...
(Date:4/1/2015)... and MOUNTAIN VIEW, Calif. ... (NYSE: BSX ) announces that it has ... a venture-backed medical device company that develops, manufactures ... (EUS) guided transluminal drainage of targeted areas within ... close this week. The Xlumena ...
(Date:4/1/2015)... ASPEN, Colo. , April 1, 2015 /PRNewswire/ ... Foundation (CKF), is pleased to sponsor the second annual ... the award, which will recognize two transplant recipients who ... is a career accomplishment, participation in a sport or ... and loved ones. "The Bounce Back ...
Breaking Medicine Technology:Pittman Motors Expands PLG Planetary Gearbox Offering 2Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3
... Sept. 21 The Association of Medical Media (AMM) ... highest-scoring medical journal advertisements Thursday, September 16, 2010.   ... annual study developed by AMM, researches physician attitudes toward ... 21 specialties from the 86 most widely-advertised products in ...
... More than one in three diabetes patients skip doses ... they have done so on average three times in the ... reality this number could be as high as six doses*, ... Insulin Therapy (GAPP™) survey, released today by Novo Nordisk. ...
Cached Medicine Technology:AMM Names 2010 Doctors' Choice Awards Winners 2AMM Names 2010 Doctors' Choice Awards Winners 3New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 2New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 3
(Date:4/1/2015)... 01, 2015 Like a mosaic slowly ... scientific understanding of the potential causes of rosacea. April ... National Rosacea Society (NRS) to educate the public on ... disorder now estimated to affect more than 16 million ... research on rosacea through its patient-funded research grants program, ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 IQ Formulations ... health and nutritional supplement companies in the U.S., today is ... testing and quality control standards for its herbal supplements.* GNC ... supply chain to ensure the accuracy of labeling on its ... veteran and IQ Formulations CEO Jay Cohen said: ...
(Date:4/1/2015)... MEETING, PA (PRWEB) April 01, 2015 ... assistance company and a subsidiary of West Corporation, today ... available at http://blog.healthadvocate.com and through the Health ... help healthcare consumers get, and stay, healthy. , “We’re ... contents available to the public,” said Martin Rosen, Executive ...
(Date:4/1/2015)... When annoying or concerning skin conditions ... weeks for an appointment with a dermatologist is the ... appointments haven’t been possible within dermatology. However, in the ... noticed demand for this level of service and are ... relief or answers to dermatological issues are to our ...
(Date:4/1/2015)... 2015 Senior Helpers of Central Texas ... Provider of Choice Award by Home Care Pulse. The Best ... given to home care providers who receive the highest satisfaction ... quality in home care. This recognition reassures you that your ... provide you with quality, trustworthy in home care. , In ...
Breaking Medicine News(10 mins):Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2
... Aug. 7 Eastern Insurance,Holdings, Inc. (Nasdaq: ... today that,it has executed a definitive agreement ... ("Employers") in a transaction valued at,approximately $14.9 ... in,debt. Employers, wholly owned subsidiary is Employers ...
... quarter of victims get to hospital quickly enough to limit ... Most people who have strokes don,t act quickly enough to ... new study finds. , "One of the problems is that ... a stroke," said Kathryn M. Rose, a research associate professor ...
... Vapotherm, the,global leader in High Flow Oxygen Therapy ... Drug Administration (FDA) for Precision,Flow(TM), the first high ... and humidification technology into one device for,the optimal ... Vapotherm products are currently used in neonatal, pediatric ...
... Aug. 7 The U.S. Government,through the U.S. ... $50,000 to the Togolese Red Cross for the ... in Togo., Beginning in mid-July, heavy rains ... the cities of Atakpame, Vogan and the capital,of ...
... Mass., Aug. 7 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... a,conference call on Thursday, August 14th, 2008 at ... 30, 2008 and discuss other matters related to,the ... To access the conference call, please dial 877-879-6201 ...
... on its own healthy tissue , , THURSDAY, Aug. 7 (HealthDay ... autoimmune diseases like lupus or rheumatoid arthritis than initially thought, ... in the Aug. 7 online issue of the journal ... in finding ways to stop the immune system,s chronic attacks ...
Cached Medicine News:Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 3Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 4Health News:Many Miss Out on Stroke Treatment 2Health News:Many Miss Out on Stroke Treatment 3Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2Health News:Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call 2Health News:Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call 3
Inquire...
Inquire...
CO2 gas object holder and knife freezer for the 8000 Series Sliding Microtome...
Steel Knife with Box for the Series 8000 Sliding Microtome. D-Profile, 240 x 33 x 13mm. 22 Degree angle, tapped to accept holder for Shandon knife sharpener....
Medicine Products: